CA9 and neoplasm: A series of betulinyl sulfamates 86, 88, and 90 have been synthesized and evaluated for their in vitro anticancer activity and carbonic anhydrase IX (CAIX) inhibition (an attractive target for tumor-selective therapy strategies in cancer cells) [53].